0
Signup/Login

18889881171

  • countryflagUS

    • Maximus, Inc. (NYSE:MMS)
    Share Price & News Technology

    NYSE:MMS Chart by TradingView

    Analyst Recommendation

    U.S. RESEARCH ROUNDUP-Bank of America, Caredx, Tesla

    Published At: March 8, 2023, 2:58 p.m.

    Author: Reuters

    U.S. RESEARCH ROUNDUP-Caredx, Oracle, Tesla

    Published At: March 8, 2023, 8:21 a.m.

    Author: Reuters

    LIVE MARKETS-U.S. stocks pop, then pare, ahead of Powell

    Published At: March 6, 2023, 9:10 p.m.

    Author: Reuters

    LIVE MARKETS-It's not the debt-ceiling donnybrook that matters, it's the level of debt

    Published At: March 6, 2023, 6:38 p.m.

    Author: Reuters

    LIVE MARKETS-Too soon to pile into broad tech universe?

    Published At: March 6, 2023, 5:40 p.m.

    Author: Reuters

    LIVE MARKETS-Soft news is good news: Factory orders dip as expected

    Published At: March 6, 2023, 4:18 p.m.

    Author: Reuters

    LIVE MARKETS-Mutual funds to become more overweight fins, underweight tech with Mar 17 GICS change -GS

    Published At: March 6, 2023, 4:03 p.m.

    Author: Reuters

    LIVE MARKETS-Who runs the world? Girls! But how much of Wall Street do they run?

    Published At: March 6, 2023, 2:46 p.m.

    Author: Reuters

    U.S. RESEARCH ROUNDUP-DR Horton, KB Home, Vir Biotechnology

    Published At: March 6, 2023, 7:35 a.m.

    Author: Reuters

    CTI Biopharma Corp <CTIC.O>: A loss of 10 cents per share anticipated for fourth quarter

    Published At: March 4, 2023, 12:02 a.m.

    Author: Reuters

    Rigel Pharmaceuticals Inc <RIGL.O>: A loss of 11 cents per share anticipated for fourth quarter

    Published At: March 3, 2023, 11:19 p.m.

    Author: Reuters

    Akili Inc <AKLI.O>: A loss of 31 cents per share anticipated for fourth quarter

    Published At: March 3, 2023, 11:07 p.m.

    Author: Reuters

    Legend Biotech Corp <LEGN.O>: A loss of 41 cents per share anticipated for third quarter

    Published At: March 3, 2023, 10:56 p.m.

    Author: Reuters

    Zymeworks Inc <ZYME.O>: Profits of $4.84 per share anticipated for fourth quarter

    Published At: March 3, 2023, 10:51 p.m.

    Author: Reuters

    Coherus BioSciences Inc <CHRS.O>: A loss of 84 cents per share anticipated for fourth quarter

    Published At: March 3, 2023, 10:37 p.m.

    Author: Reuters

    Cara Therapeutics Inc <CARA.O>: A loss of 32 cents per share anticipated for fourth quarter

    Published At: March 3, 2023, 10:03 p.m.

    Author: Reuters

    Tabula Rasa HealthCare Inc <TRHC.O>: A loss of 6 cents per share anticipated for fourth quarter

    Published At: March 3, 2023, 9:25 p.m.

    Author: Reuters

    Akoya Biosciences Inc <AKYA.O>: A loss of 43 cents per share anticipated for fourth quarter

    Published At: March 3, 2023, 9:24 p.m.

    Author: Reuters

    Zynex Inc <ZYXI.O>: Profits of 19 cents per share anticipated for fourth quarter

    Published At: March 3, 2023, 9:17 p.m.

    Author: Reuters

    LIVE MARKETS-U.S. stocks end higher as yields drop

    Published At: March 3, 2023, 9:11 p.m.

    Author: Reuters

    Lipocine Inc <LPCN.O>: A loss of 3 cents per share anticipated for fourth quarter

    Published At: March 3, 2023, 5:15 p.m.

    Author: Reuters

    Magenta Therapeutics Inc <MGTA.O>: A loss of 27 cents per share anticipated for fourth quarter

    Published At: March 3, 2023, 5:03 p.m.

    Author: Reuters

    Alaunos Therapeutics Inc <TCRT.O>: A loss of 7 cents per share anticipated for fourth quarter

    Published At: March 3, 2023, 4:09 p.m.

    Author: Reuters

    Voyager Therapeutics Inc <VYGR.O>: A loss of 55 cents per share anticipated for fourth quarter

    Published At: March 3, 2023, 3:45 p.m.

    Author: Reuters

    Seres Therapeutics Inc <MCRB.O>: A loss of 46 cents per share anticipated for fourth quarter

    Published At: March 3, 2023, 3:41 p.m.

    Author: Reuters

    908 Devices Inc. <MASS.O>: A loss of 26 cents per share anticipated for fourth quarter

    Published At: March 3, 2023, 2:59 p.m.

    Author: Reuters

    Protara Therapeutics Inc <TARA.O>: A loss of 75 cents per share anticipated for fourth quarter

    Published At: March 3, 2023, 2:53 p.m.

    Author: Reuters

    Neuronetics Inc <STIM.O>: A loss of 38 cents per share anticipated for fourth quarter

    Published At: March 3, 2023, 2:50 p.m.

    Author: Reuters

    Cyclacel Pharmaceuticals Inc <CYCC.O>: A loss of 48 cents per share anticipated for fourth quarter

    Published At: March 3, 2023, 2:45 p.m.

    Author: Reuters

    Sutro Biopharma Inc <STRO.O>: A loss of 62 cents per share anticipated for fourth quarter

    Published At: March 3, 2023, 2:22 p.m.

    Author: Reuters

    Lyra Therapeutics Inc <LYRA.O>: A loss of 41 cents per share anticipated for fourth quarter

    Published At: March 3, 2023, 1:50 p.m.

    Author: Reuters

    Scholar Rock Holding Corp <SRRK.O>: A loss of 57 cents per share anticipated for fourth quarter

    Published At: March 3, 2023, 1:33 p.m.

    Author: Reuters

    Corbus Pharmaceuticals Holdings Inc <CRBP.O>: A loss of $2.1 per share anticipated for fourth quarter

    Published At: March 3, 2023, 1:09 p.m.

    Author: Reuters

    Oncorus Inc <ONCR.O>: A loss of 76 cents per share anticipated for fourth quarter

    Published At: March 3, 2023, 12:07 p.m.

    Author: Reuters

    Instil Bio Inc <TIL.O>: A loss of 41 cents per share anticipated for fourth quarter

    Published At: March 3, 2023, 12:06 p.m.

    Author: Reuters

    Keros Therapeutics Inc <KROS.O>: A loss of $1.1 per share anticipated for fourth quarter

    Published At: March 3, 2023, 11:55 a.m.

    Author: Reuters

    GeoVax Labs Inc <GOVX.O>: A loss of 20 cents per share anticipated for fourth quarter

    Published At: March 3, 2023, 11:50 a.m.

    Author: Reuters

    Cidara Therapeutics Inc <CDTX.O>: A loss of 17 cents per share anticipated for fourth quarter

    Published At: March 3, 2023, 11:38 a.m.

    Author: Reuters

    Neximmune Inc <NEXI.O>: A loss of 53 cents per share anticipated for fourth quarter

    Published At: March 3, 2023, 11:30 a.m.

    Author: Reuters

    DURECT Corp <DRRX.O>: A loss of 55 cents per share anticipated for fourth quarter

    Published At: March 3, 2023, 11:22 a.m.

    Author: Reuters

    U.S. RESEARCH ROUNDUP-Itron, Marathon Petroleum, P&G

    Published At: March 3, 2023, 8:29 a.m.

    Author: Reuters

    U.S. RESEARCH ROUNDUP-Itron, Marathon Petroleum, Radius Global Infrastructure

    Published At: March 3, 2023, 7:28 a.m.

    Author: Reuters

    LIVE MARKETS-Will China’s manufacturing growth lower inflation?

    Published At: March 2, 2023, 6:36 p.m.

    Author: Reuters

    LIVE MARKETS-U.S. debt ceiling: Will Treasury Secretary Yellen's spinning plates wobble and fall?

    Published At: March 2, 2023, 5:24 p.m.

    Author: Reuters

    Marvell Technology Inc <MRVL.O>: Profits of 47 cents per share anticipated for first quarter

    Published At: March 1, 2023, 12:07 a.m.

    Author: Reuters

    Viant Technology Inc <DSP.O>: A loss of 13 cents per share anticipated for fourth quarter

    Published At: Feb. 28, 2023, 9:54 p.m.

    Author: Reuters

    Longboard Pharmaceuticals Inc <LBPH.O>: A loss of 69 cents per share anticipated for fourth quarter

    Published At: Feb. 28, 2023, 9:50 p.m.

    Author: Reuters

    Puma Biotechnology Inc <PBYI.O>: Profits of 5 cents per share anticipated for fourth quarter

    Published At: Feb. 28, 2023, 9:47 p.m.

    Author: Reuters

    Neuropace Inc <NPCE.O>: A loss of 49 cents per share anticipated for fourth quarter

    Published At: Feb. 28, 2023, 9:39 p.m.

    Author: Reuters

    Singular Genomics Systems Inc <OMIC.O>: A loss of 43 cents per share anticipated for fourth quarter

    Published At: Feb. 28, 2023, 9:36 p.m.

    Author: Reuters

    Ardelyx Inc <ARDX.O>: Breakeven results per share anticipated for fourth quarter

    Published At: Feb. 28, 2023, 9:23 p.m.

    Author: Reuters

    Syros Pharmaceuticals Inc <SYRS.O>: A loss of $1.35 per share anticipated for fourth quarter

    Published At: Feb. 28, 2023, 2:58 p.m.

    Author: Reuters

    bluebird bio Inc <BLUE.O>: A loss of 60 cents per share anticipated for fourth quarter

    Published At: Feb. 28, 2023, 11:16 a.m.

    Author: Reuters

    NextCure Inc <NXTC.O>: A loss of 66 cents per share anticipated for fourth quarter

    Published At: Feb. 28, 2023, 2:27 a.m.

    Author: Reuters

    Gossamer Bio Inc <GOSS.O>: A loss of 62 cents per share anticipated for fourth quarter

    Published At: Feb. 28, 2023, 2:09 a.m.

    Author: Reuters

    Cytokinetics Inc <CYTK.O>: A loss of $1.21 per share anticipated for fourth quarter

    Published At: Feb. 28, 2023, 1:51 a.m.

    Author: Reuters

    Veeva Systems Inc <VEEV.N>: Profits of $1.04 per share anticipated for first quarter

    Published At: Feb. 28, 2023, 1:34 a.m.

    Author: Reuters

    Ginkgo Bioworks Holdings Inc <DNA.N>: A loss of 21 cents per share anticipated for fourth quarter

    Published At: Feb. 28, 2023, 12:09 a.m.

    Author: Reuters

    Inovio Pharmaceuticals Inc <INO.O>: A loss of 17 cents per share anticipated for fourth quarter

    Published At: Feb. 27, 2023, 11:33 p.m.

    Author: Reuters

    Meridianlink Inc <MLNK.N>: Profits of 1 cents per share anticipated for fourth quarter

    Published At: Feb. 27, 2023, 11:11 p.m.

    Author: Reuters

    Lumos Pharma Inc <LUMO.O>: A loss of 93 cents per share anticipated for fourth quarter

    Published At: Feb. 27, 2023, 11:10 p.m.

    Author: Reuters

    Atreca Inc <BCEL.O>: A loss of 59 cents per share anticipated for fourth quarter

    Published At: Feb. 27, 2023, 10:28 p.m.

    Author: Reuters

    Veradigm Inc <MDRX.O>: Profits of 27 cents per share anticipated for fourth quarter

    Published At: Feb. 27, 2023, 9:26 p.m.

    Author: Reuters

    Passage Bio Inc <PASG.O>: A loss of 52 cents per share anticipated for fourth quarter

    Published At: Feb. 27, 2023, 7:31 p.m.

    Author: Reuters

    WAVE Life Sciences Ltd <WVE.O>: A loss of 41 cents per share anticipated for fourth quarter

    Published At: Feb. 27, 2023, 7:30 p.m.

    Author: Reuters

    ImmunoGen Inc <IMGN.O>: A loss of 30 cents per share anticipated for fourth quarter

    Published At: Feb. 27, 2023, 7:21 p.m.

    Author: Reuters

    PAR Technology Corp <PAR.N>: A loss of 45 cents per share anticipated for fourth quarter

    Published At: Feb. 27, 2023, 6:43 p.m.

    Author: Reuters

    Fulcrum Therapeutics Inc <FULC.O>: A loss of 49 cents per share anticipated for fourth quarter

    Published At: Feb. 27, 2023, 5:27 p.m.

    Author: Reuters

    Intra-Cellular Therapies Inc <ITCI.O>: A loss of 59 cents per share anticipated for fourth quarter

    Published At: Feb. 27, 2023, 3:57 p.m.

    Author: Reuters

    Amicus Therapeutics Inc <FOLD.O>: A loss of 13 cents per share anticipated for fourth quarter

    Published At: Feb. 27, 2023, 3:42 p.m.

    Author: Reuters

    ACI Worldwide Inc <ACIW.O>: Profits of 91 cents per share anticipated for fourth quarter

    Published At: Feb. 27, 2023, 3:31 p.m.

    Author: Reuters

    GlycoMimetics Inc <GLYC.O>: A loss of 17 cents per share anticipated for fourth quarter

    Published At: Feb. 27, 2023, 3:01 p.m.

    Author: Reuters

    IVERIC bio Inc <ISEE.O>: A loss of 37 cents per share anticipated for fourth quarter

    Published At: Feb. 27, 2023, 2:43 p.m.

    Author: Reuters

    Rhythm Pharmaceuticals Inc <RYTM.O>: A loss of 81 cents per share anticipated for fourth quarter

    Published At: Feb. 27, 2023, 12:27 p.m.

    Author: Reuters

    Terns Pharmaceuticals Inc <TERN.O>: A loss of 43 cents per share anticipated for fourth quarter

    Published At: Feb. 27, 2023, 11:19 a.m.

    Author: Reuters

    Acer Therapeutics Inc <ACER.O>: A loss of 37 cents per share anticipated for fourth quarter

    Published At: Feb. 25, 2023, 3:15 a.m.

    Author: Reuters

    CareDx Inc <CDNA.O>: A loss of 9 cents per share anticipated for fourth quarter

    Published At: Feb. 25, 2023, 3:10 a.m.

    Author: Reuters

    Sarepta Therapeutics Inc <SRPT.O>: A loss of $1.35 per share anticipated for fourth quarter

    Published At: Feb. 25, 2023, 3:10 a.m.

    Author: Reuters

    Arcutis Biotherapeutics Inc <ARQT.O>: A loss of $1.42 per share anticipated for fourth quarter

    Published At: Feb. 25, 2023, 3:10 a.m.

    Author: Reuters

    Cytek Biosciences Inc <CTKB.O>: Profits of 5 cents per share anticipated for fourth quarter

    Published At: Feb. 25, 2023, 3:10 a.m.

    Author: Reuters

    Horizon Technology Finance Corp <HRZN.O>: Profits of 39 cents per share anticipated for fourth quarter

    Published At: Feb. 25, 2023, 3:09 a.m.

    Author: Reuters

    Atea Pharmaceuticals Inc <AVIR.O>: A loss of 45 cents per share anticipated for fourth quarter

    Published At: Feb. 25, 2023, 3:09 a.m.

    Author: Reuters

    Iovance Biotherapeutics Inc <IOVA.O>: A loss of 64 cents per share anticipated for fourth quarter

    Published At: Feb. 25, 2023, 3:08 a.m.

    Author: Reuters

    Syndax Pharmaceuticals Inc <SNDX.O>: A loss of 65 cents per share anticipated for fourth quarter

    Published At: Feb. 25, 2023, 3:08 a.m.

    Author: Reuters

    Novavax Inc <NVAX.O>: A loss of 92 cents per share anticipated for fourth quarter

    Published At: Feb. 25, 2023, 3:08 a.m.

    Author: Reuters

    Health Catalyst Inc <HCAT.O>: A loss of 11 cents per share anticipated for fourth quarter

    Published At: Feb. 25, 2023, 3:08 a.m.

    Author: Reuters

    Olema Pharmaceuticals Inc <OLMA.O>: A loss of 65 cents per share anticipated for fourth quarter

    Published At: Feb. 25, 2023, 3:08 a.m.

    Author: Reuters

    Arcturus Therapeutics Holdings Inc <ARCT.O>: Profits of 98 cents per share anticipated for fourth quarter

    Published At: Feb. 25, 2023, 1:59 a.m.

    Author: Reuters

    Revolution Medicines Inc <RVMD.O>: A loss of 82 cents per share anticipated for fourth quarter

    Published At: Feb. 25, 2023, 1:47 a.m.

    Author: Reuters

    Avid Technology Inc <AVID.O>: Profits of 48 cents per share anticipated for fourth quarter

    Published At: Feb. 25, 2023, 1:32 a.m.

    Author: Reuters

    Revance Therapeutics Inc <RVNC.O>: A loss of 95 cents per share anticipated for fourth quarter

    Published At: Feb. 25, 2023, 1:12 a.m.

    Author: Reuters

    Omnicell Inc <OMCL.O>: Profits of 9 cents per share anticipated for fourth quarter

    Published At: Feb. 25, 2023, 1:09 a.m.

    Author: Reuters

    CytomX Therapeutics Inc <CTMX.O>: A loss of 24 cents per share anticipated for fourth quarter

    Published At: Feb. 25, 2023, 12:45 a.m.

    Author: Reuters

    Marqeta Inc <MQ.O>: A loss of 9 cents per share anticipated for fourth quarter

    Published At: Feb. 25, 2023, 12:23 a.m.

    Author: Reuters

    Forge Global Holdings Inc <FRGE.N>: A loss of 15 cents per share anticipated for fourth quarter

    Published At: Feb. 25, 2023, 12:06 a.m.

    Author: Reuters

    Invitae Corp <NVTA.N>: A loss of 53 cents per share anticipated for fourth quarter

    Published At: Feb. 24, 2023, 11:47 p.m.

    Author: Reuters

    Agilent Technologies Inc <A.N>: Profits of $1.3 per share anticipated for first quarter

    Published At: Feb. 24, 2023, 11:42 p.m.

    Author: Reuters

    Regenxbio Inc <RGNX.O>: A loss of $1.23 per share anticipated for fourth quarter

    Published At: Feb. 24, 2023, 11:36 p.m.

    Author: Reuters

    ICAD Inc <ICAD.O>: A loss of 14 cents per share anticipated for fourth quarter

    Published At: Feb. 24, 2023, 11:02 p.m.

    Author: Reuters

    Intercept Pharmaceuticals Inc <ICPT.O>: A loss of 16 cents per share anticipated for fourth quarter

    Published At: Feb. 24, 2023, 7:38 p.m.

    Author: Reuters

    Chimerix Inc <CMRX.O>: A loss of 24 cents per share anticipated for fourth quarter

    Published At: Feb. 24, 2023, 7:38 p.m.

    Author: Reuters

    Axsome Therapeutics Inc <AXSM.O>: A loss of $1.14 per share anticipated for fourth quarter

    Published At: Feb. 24, 2023, 7:37 p.m.

    Author: Reuters

    Clover Health Investments Corp <CLOV.O>: A loss of 26 cents per share anticipated for fourth quarter

    Published At: Feb. 24, 2023, 7:37 p.m.

    Author: Reuters

    Ocugen Inc <OCGN.O>: A loss of 10 cents per share anticipated for fourth quarter

    Published At: Feb. 24, 2023, 7:36 p.m.

    Author: Reuters

    Altimmune Inc <ALT.O>: A loss of 50 cents per share anticipated for fourth quarter

    Published At: Feb. 24, 2023, 7:35 p.m.

    Author: Reuters

    Reata Pharmaceuticals Inc <RETA.O>: A loss of $2.22 per share anticipated for fourth quarter

    Published At: Feb. 24, 2023, 7:35 p.m.

    Author: Reuters

    Quanterix Corp <QTRX.O>: A loss of 47 cents per share anticipated for fourth quarter

    Published At: Feb. 24, 2023, 7:17 p.m.

    Author: Reuters

    Avalo Therapeutics Inc <AVTX.O>: A loss of 73 cents per share anticipated for fourth quarter

    Published At: Feb. 24, 2023, 6:55 p.m.

    Author: Reuters

    Mersana Therapeutics Inc <MRSN.O>: A loss of 50 cents per share anticipated for fourth quarter

    Published At: Feb. 24, 2023, 6:40 p.m.

    Author: Reuters

    Bioatla Inc <BCAB.O>: A loss of 70 cents per share anticipated for fourth quarter

    Published At: Feb. 24, 2023, 6:32 p.m.

    Author: Reuters

    Krystal Biotech Inc <KRYS.O>: A loss of $1.32 per share anticipated for fourth quarter

    Published At: Feb. 24, 2023, 6:29 p.m.

    Author: Reuters

    Minerva Neurosciences Inc <NERV.O>: A loss of 92 cents per share anticipated for fourth quarter

    Published At: Feb. 24, 2023, 6:21 p.m.

    Author: Reuters

    Albireo Pharma Inc <ALBO.O>: A loss of $1.83 per share anticipated for fourth quarter

    Published At: Feb. 24, 2023, 5:56 p.m.

    Author: Reuters

    Lexicon Pharmaceuticals Inc <LXRX.O>: A loss of 13 cents per share anticipated for fourth quarter

    Published At: Feb. 24, 2023, 5:42 p.m.

    Author: Reuters

    Jounce Therapeutics Inc <JNCE.O>: A loss of 9 cents per share anticipated for fourth quarter

    Published At: Feb. 24, 2023, 5:41 p.m.

    Author: Reuters

    ALX Oncology Holdings Inc <ALXO.O>: A loss of 89 cents per share anticipated for fourth quarter

    Published At: Feb. 24, 2023, 5:27 p.m.

    Author: Reuters

    PMV Pharmaceuticals Inc <PMVP.O>: A loss of 44 cents per share anticipated for fourth quarter

    Published At: Feb. 24, 2023, 5:21 p.m.

    Author: Reuters

    Surface Oncology Inc <SURF.O>: A loss of 33 cents per share anticipated for fourth quarter

    Published At: Feb. 24, 2023, 5:19 p.m.

    Author: Reuters

    Beam Therapeutics Inc <BEAM.O>: A loss of $1.33 per share anticipated for fourth quarter

    Published At: Feb. 24, 2023, 5:03 p.m.

    Author: Reuters

    Inhibrx Inc <INBX.O>: A loss of 79 cents per share anticipated for fourth quarter

    Published At: Feb. 24, 2023, 4:51 p.m.

    Author: Reuters

    Nuvation Bio Inc <NUVB.N>: A loss of 11 cents per share anticipated for fourth quarter

    Published At: Feb. 24, 2023, 3:12 p.m.

    Author: Reuters

    Kodiak Sciences Inc <KOD.O>: A loss of $1.53 per share anticipated for fourth quarter

    Published At: Feb. 24, 2023, 2:34 p.m.

    Author: Reuters

    Denali Therapeutics Inc <DNLI.O>: A loss of 79 cents per share anticipated for fourth quarter

    Published At: Feb. 24, 2023, 2:32 p.m.

    Author: Reuters

    ADC Therapeutics SA <ADCT.N>: A loss of 29 cents per share anticipated for fourth quarter

    Published At: Feb. 24, 2023, 2:05 p.m.

    Author: Reuters

    Celldex Therapeutics Inc <CLDX.O>: A loss of 59 cents per share anticipated for fourth quarter

    Published At: Feb. 24, 2023, 2:01 p.m.

    Author: Reuters

    Heron Therapeutics Inc <HRTX.O>: A loss of 28 cents per share anticipated for fourth quarter

    Published At: Feb. 24, 2023, 12:44 p.m.

    Author: Reuters

    Bionano Genomics Inc <BNGO.O>: A loss of 11 cents per share anticipated for fourth quarter

    Published At: Feb. 24, 2023, 12:43 p.m.

    Author: Reuters

    Cassava Sciences Inc <SAVA.O>: A loss of 56 cents per share anticipated for fourth quarter

    Published At: Feb. 24, 2023, 12:13 p.m.

    Author: Reuters

    NGM Biopharmaceuticals Inc <NGM.O>: A loss of 51 cents per share anticipated for fourth quarter

    Published At: Feb. 24, 2023, 11:55 a.m.

    Author: Reuters

    Akebia Therapeutics Inc <AKBA.O>: A loss of 19 cents per share anticipated for fourth quarter

    Published At: Feb. 24, 2023, 11:28 a.m.

    Author: Reuters

    Phathom Pharmaceuticals Inc <PHAT.O>: A loss of $1.35 per share anticipated for fourth quarter

    Published At: Feb. 24, 2023, 11:10 a.m.

    Author: Reuters

    Allakos Inc <ALLK.O>: A loss of 57 cents per share anticipated for fourth quarter

    Published At: Feb. 24, 2023, 11:02 a.m.

    Author: Reuters

    U.S. RESEARCH ROUNDUP-C4 Therapeutics, Nvidia, WW Grainger

    Published At: Feb. 24, 2023, 7:21 a.m.

    Author: Reuters

    LIVE MARKETS-Defense stocks: A year into the Russia-Ukraine war

    Published At: Feb. 23, 2023, 6:37 p.m.

    Author: Reuters

    REFILE-LIVE MARKETS-The show is not over for high dividend-yielding stocks

    Published At: Feb. 23, 2023, 6:14 p.m.

    Author: Reuters

    LIVE MARKETS-The show is not over for high dividend-yielding stocks

    Published At: Feb. 23, 2023, 5:57 p.m.

    Author: Reuters

    LIVE MARKETS-Irrationality makes its return, right on cue

    Published At: Feb. 23, 2023, 5:05 p.m.

    Author: Reuters

    U.S. RESEARCH ROUNDUP-Alignment Healthcare, Centene, Oak Street Health

    Published At: Feb. 23, 2023, 9:14 a.m.

    Author: Reuters

    U.S. RESEARCH ROUNDUP-Cinemark Holdings, Commercial Metals Co, Nvidia

    Published At: Feb. 23, 2023, 7:26 a.m.

    Author: Reuters

    Intuit Inc <INTU.O>: Profits of $1.44 per share anticipated for first quarter

    Published At: Feb. 22, 2023, 3:27 a.m.

    Author: Reuters

    Berkeley Lights Inc <BLI.O>: A loss of 27 cents per share anticipated for fourth quarter

    Published At: Feb. 22, 2023, 1:47 a.m.

    Author: Reuters

    MannKind Corp <MNKD.O>: A loss of 6 cents per share anticipated for fourth quarter

    Published At: Feb. 21, 2023, 11:25 p.m.

    Author: Reuters

    Nautilus Biotechnology Inc <NAUT.O>: A loss of 15 cents per share anticipated for fourth quarter

    Published At: Feb. 21, 2023, 7:25 p.m.

    Author: Reuters

    Akero Therapeutics Inc <AKRO.O>: A loss of 80 cents per share anticipated for fourth quarter

    Published At: Feb. 21, 2023, 1:31 p.m.

    Author: Reuters

    Kymera Therapeutics Inc <KYMR.O>: A loss of 63 cents per share anticipated for fourth quarter

    Published At: Feb. 21, 2023, 1:25 p.m.

    Author: Reuters

    Shattuck Labs Inc <STTK.O>: A loss of 63 cents per share anticipated for fourth quarter

    Published At: Feb. 21, 2023, 1:19 p.m.

    Author: Reuters

    Vaxart Inc <VXRT.O>: A loss of 23 cents per share anticipated for fourth quarter

    Published At: Feb. 21, 2023, 3:04 a.m.

    Author: Reuters

    Transmedics Group Inc <TMDX.O>: A loss of 30 cents per share anticipated for fourth quarter

    Published At: Feb. 21, 2023, 3:02 a.m.

    Author: Reuters

    Y-mAbs Therapeutics Inc <YMAB.O>: A loss of 46 cents per share anticipated for fourth quarter

    Published At: Feb. 21, 2023, 3:02 a.m.

    Author: Reuters

    Ionis Pharmaceuticals Inc <IONS.O>: A loss of 92 cents per share anticipated for fourth quarter

    Published At: Feb. 20, 2023, 1:59 p.m.

    Author: Reuters

    Curis Inc <CRIS.O>: A loss of 13 cents per share anticipated for fourth quarter

    Published At: Feb. 20, 2023, 12:11 p.m.

    Author: Reuters

    Cardiff Oncology Inc <CRDF.O>: A loss of 23 cents per share anticipated for fourth quarter

    Published At: Feb. 20, 2023, 11:41 a.m.

    Author: Reuters

    Alector Inc <ALEC.O>: A loss of 46 cents per share anticipated for fourth quarter

    Published At: Feb. 20, 2023, 11:30 a.m.

    Author: Reuters

    Zymeworks Inc <ZYME.O>: Profits of $3.12 per share anticipated for fourth quarter

    Published At: Feb. 20, 2023, 11:20 a.m.

    Author: Reuters

    MacroGenics Inc <MGNX.O>: Profits of 25 cents per share anticipated for fourth quarter

    Published At: Feb. 20, 2023, 11:04 a.m.

    Author: Reuters

    Generation Bio Co <GBIO.O>: A loss of 58 cents per share anticipated for fourth quarter

    Published At: Feb. 20, 2023, 11:01 a.m.

    Author: Reuters

    PTC Therapeutics Inc <PTCT.O>: A loss of $1.59 per share anticipated for fourth quarter

    Published At: Feb. 18, 2023, 12:16 a.m.

    Author: Reuters

    Exact Sciences Corp <EXAS.O>: A loss of 84 cents per share anticipated for fourth quarter

    Published At: Feb. 17, 2023, 10:50 p.m.

    Author: Reuters

    Halozyme Therapeutics Inc <HALO.O>: Profits of 47 cents per share anticipated for fourth quarter

    Published At: Feb. 17, 2023, 9:28 p.m.

    Author: Reuters

    G1 Therapeutics Inc <GTHX.O>: A loss of 84 cents per share anticipated for fourth quarter

    Published At: Feb. 17, 2023, 3:23 p.m.

    Author: Reuters

    Tactile Systems Technology Inc <TCMD.O>: Profits of 14 cents per share anticipated for fourth quarter

    Published At: Feb. 17, 2023, 2:40 p.m.

    Author: Reuters

    BioCryst Pharmaceuticals Inc <BCRX.O>: A loss of 17 cents per share anticipated for fourth quarter

    Published At: Feb. 17, 2023, 1:48 p.m.

    Author: Reuters

    Blacksky Technology Inc <BKSY.N>: A loss of 16 cents per share anticipated for fourth quarter

    Published At: Feb. 17, 2023, 12:32 p.m.

    Author: Reuters

    Xencor Inc <XNCR.O>: A loss of 79 cents per share anticipated for fourth quarter

    Published At: Feb. 17, 2023, 12:14 p.m.

    Author: Reuters

    Arcus Biosciences Inc <RCUS.N>: A loss of $1.07 per share anticipated for fourth quarter

    Published At: Feb. 17, 2023, 12:04 p.m.

    Author: Reuters

    Allogene Therapeutics Inc <ALLO.O>: A loss of 70 cents per share anticipated for fourth quarter

    Published At: Feb. 17, 2023, 11:01 a.m.

    Author: Reuters

    LIVE MARKETS-Wall St drops more than 1%

    Published At: Feb. 16, 2023, 9:22 p.m.

    Author: Reuters

    UPDATE 3-Credo slumps as top customer of data center cable maker cuts orders

    Published At: Feb. 15, 2023, 9:03 p.m.

    Author: Reuters

    UPDATE 2-Credo slumps as top customer of data center cable maker cuts orders

    Published At: Feb. 15, 2023, 6:24 p.m.

    Author: Reuters

    Pacific Biosciences of California Inc <PACB.O>: A loss of 36 cents per share anticipated for fourth quarter

    Published At: Feb. 14, 2023, 11:52 p.m.

    Author: Reuters

    Ultragenyx Pharmaceutical Inc <RARE.O>: A loss of $2.14 per share anticipated for fourth quarter

    Published At: Feb. 14, 2023, 9:09 p.m.

    Author: Reuters

    SAGE Therapeutics Inc <SAGE.O>: A loss of $2.39 per share anticipated for fourth quarter

    Published At: Feb. 14, 2023, 3:26 p.m.

    Author: Reuters

    Syneos Health Inc <SYNH.O>: Profits of $1.2 per share anticipated for fourth quarter

    Published At: Feb. 14, 2023, 2:45 p.m.

    Author: Reuters

    Alkermes Plc <ALKS.O>: Profits of 5 cents per share anticipated for fourth quarter

    Published At: Feb. 14, 2023, 2:33 p.m.

    Author: Reuters

    Ironwood Pharmaceuticals Inc <IRWD.O>: Profits of 27 cents per share anticipated for fourth quarter

    Published At: Feb. 14, 2023, 2:13 p.m.

    Author: Reuters

    Blueprint Medicines Corp <BPMC.O>: A loss of $2.65 per share anticipated for fourth quarter

    Published At: Feb. 14, 2023, 1:35 p.m.

    Author: Reuters

    Ascendis Pharma A/S <ASND.O>: A loss of €2.56 per share anticipated for fourth quarter

    Published At: Feb. 14, 2023, 11:29 a.m.

    Author: Reuters

    U.S. RESEARCH ROUNDUP- Arista Networks, Dominion Energy, TransDigm Group

    Published At: Feb. 14, 2023, 7:14 a.m.

    Author: Reuters

    Quidelortho Corp <QDEL.O>: Profits of $1.43 per share anticipated for fourth quarter

    Published At: Feb. 14, 2023, 3:03 a.m.

    Author: Reuters

    Aethlon Medical Inc <AEMD.O>: A loss of 8 cents per share anticipated for fourth quarter

    Published At: Feb. 11, 2023, 3:05 a.m.

    Author: Reuters

    Adaptive Biotechnologies Corp <ADPT.O>: A loss of 35 cents per share anticipated for fourth quarter

    Published At: Feb. 11, 2023, 2:18 a.m.

    Author: Reuters

    Prothena Corporation PLC <PRTA.O>: A loss of 47 cents per share anticipated for fourth quarter

    Published At: Feb. 11, 2023, 1:26 a.m.

    Author: Reuters

    Skywater Technology Inc <SKYT.O>: A loss of 11 cents per share anticipated for fourth quarter

    Published At: Feb. 11, 2023, 12:30 a.m.

    Author: Reuters

    Outset Medical Inc <OM.O>: A loss of 86 cents per share anticipated for fourth quarter

    Published At: Feb. 11, 2023, 12:21 a.m.

    Author: Reuters

    Medpace Holdings Inc <MEDP.O>: Profits of $1.79 per share anticipated for fourth quarter

    Published At: Feb. 10, 2023, 10:16 p.m.

    Author: Reuters

    Transphorm Technology Inc <TGAN.O>: A loss of 10 cents per share anticipated for fourth quarter

    Published At: Feb. 10, 2023, 9:31 p.m.

    Author: Reuters

    Blueprint Medicines Corp <BPMC.O>: A loss of $2.64 per share anticipated for fourth quarter

    Published At: Feb. 10, 2023, 3:48 p.m.

    Author: Reuters

    Charles River Laboratories International Inc <CRL.N>: Profits of $2.75 per share anticipated for fourth quarter

    Published At: Feb. 10, 2023, 3:45 p.m.

    Author: Reuters

    PerkinElmer Inc <PKI.N>: Profits of $1.62 per share anticipated for fourth quarter

    Published At: Feb. 10, 2023, 3:37 p.m.

    Author: Reuters

    Inmode Ltd <INMD.O>: Profits of 67 cents per share anticipated for fourth quarter

    Published At: Feb. 10, 2023, 3:09 p.m.

    Author: Reuters

    Outlook Therapeutics Inc <OTLK.O>: A loss of 5 cents per share anticipated for fourth quarter

    Published At: Feb. 10, 2023, 2:13 p.m.

    Author: Reuters

    Omnicell Inc <OMCL.O>: Profits of 10 cents per share anticipated for fourth quarter

    Published At: Feb. 10, 2023, 11:48 a.m.

    Author: Reuters

    LIVE MARKETS-If a recession hits, it may be time to take on risk

    Published At: Feb. 8, 2023, 6:37 p.m.

    Author: Reuters

    LIVE MARKETS-Robots: Bumbling buckets of bolts or inflation fighting friends?

    Published At: Feb. 8, 2023, 5:30 p.m.

    Author: Reuters

    LIVE MARKETS-Powell better heed history, else he may be doomed to repeat it -Cresset

    Published At: Feb. 8, 2023, 4:55 p.m.

    Author: Reuters

    LIVE MARKETS-Microsoft's Bing, Google duke it out in escalating chatbot war

    Published At: Feb. 8, 2023, 4:23 p.m.

    Author: Reuters

    LIVE MARKETS-Wall Street is red with eyes on Fed, earnings

    Published At: Feb. 8, 2023, 3:22 p.m.

    Author: Reuters

    IQVIA Holdings Inc <IQV.N>: Profits of $2.76 per share anticipated for fourth quarter

    Published At: Feb. 8, 2023, 2:30 p.m.

    Author: Reuters

    U.S. RESEARCH ROUNDUP-BP, Chipotle Mexican Grill, Hain Celestial

    Published At: Feb. 8, 2023, 2:16 p.m.

    Author: Reuters

    Sensus Healthcare Inc <SRTS.O>: Profits of 23 cents per share anticipated for fourth quarter

    Published At: Feb. 7, 2023, 11:48 p.m.

    Author: Reuters

    Bruker Corp <BRKR.O>: Profits of 72 cents per share anticipated for fourth quarter

    Published At: Feb. 7, 2023, 7:34 p.m.

    Author: Reuters

    Dynatronics Corp <DYNT.O>: A loss of 15 cents per share anticipated for fourth quarter

    Published At: Feb. 7, 2023, 7:32 p.m.

    Author: Reuters

    Atara Biotherapeutics Inc <ATRA.O>: A loss of 51 cents per share anticipated for fourth quarter

    Published At: Feb. 7, 2023, 1:01 a.m.

    Author: Reuters

    Anavex Life Sciences Corp <AVXL.O>: A loss of 19 cents per share anticipated for fourth quarter

    Published At: Feb. 3, 2023, 3:44 p.m.

    Author: Reuters

    Karyopharm Therapeutics Inc <KPTI.O>: A loss of 35 cents per share anticipated for fourth quarter

    Published At: Feb. 3, 2023, 2:53 p.m.

    Author: Reuters

    Rezolute Inc <RZLT.O>: A loss of 32 cents per share anticipated for fourth quarter

    Published At: Feb. 3, 2023, 11:33 a.m.

    Author: Reuters

    U.S. RESEARCH ROUNDUP-Boeing, First Foundation, Spirit Aerosystems Holdings

    Published At: Feb. 3, 2023, 7:13 a.m.

    Author: Reuters

    U.S. RESEARCH ROUNDUP-Evelo Biosciences, FedEx, Meta Platforms

    Published At: Feb. 2, 2023, 6:52 p.m.

    Author: Reuters

    U.S. RESEARCH ROUNDUP-Evelo Biosciences, FedEx, Meta

    Published At: Feb. 2, 2023, 3:21 p.m.

    Author: Reuters

    Regeneron Pharmaceuticals Inc <REGN.O>: Profits of $10.03 per share anticipated for fourth quarter

    Published At: Feb. 1, 2023, 1:47 p.m.

    Author: Reuters

    RPT-U.S. RESEARCH ROUNDUP-Evoqua Water Technologies, Taysha Gene Therapies, Veradigm

    Published At: Feb. 1, 2023, 11:50 a.m.

    Author: Reuters

    Immunovant Inc <IMVT.O>: A loss of 39 cents per share anticipated for fourth quarter

    Published At: Jan. 31, 2023, 2:53 p.m.

    Author: Reuters

    LIVE MARKETS-Month-end and the Fed will prove to be bitter pills -Morgan Stanley

    Published At: Jan. 30, 2023, 5:39 p.m.

    Author: Reuters

    Replimune Group Inc <REPL.O>: A loss of 75 cents per share anticipated for fourth quarter

    Published At: Jan. 30, 2023, 3:08 p.m.

    Author: Reuters

    Thermo Fisher Scientific Inc <TMO.N>: Profits of $5.19 per share anticipated for fourth quarter

    Published At: Jan. 30, 2023, 1:55 p.m.

    Author: Reuters

    Boston Scientific Corp <BSX.N>: Profits of 47 cents per share anticipated for fourth quarter

    Published At: Jan. 30, 2023, 1:37 p.m.

    Author: Reuters

    Varex Imaging Corp <VREX.O>: Profits of 20 cents per share anticipated for fourth quarter

    Published At: Jan. 28, 2023, 12:01 a.m.

    Author: Reuters

    Edwards Lifesciences Corp <EW.N>: Profits of 61 cents per share anticipated for fourth quarter

    Published At: Jan. 27, 2023, 10:45 p.m.

    Author: Reuters

    U.S. RESEARCH ROUNDUP-Driven Brands Holdings, McCormick & Co, Standex International

    Published At: Jan. 27, 2023, 5:41 p.m.

    Author: Reuters

    UPDATE 1-Optimism over China, peak bond yields draw flows into stocks -BofA

    Published At: Jan. 27, 2023, 3:31 p.m.

    Author: Reuters

    Spotify Technology SA <SPOT.N>: A loss of €1.28 per share anticipated for fourth quarter

    Published At: Jan. 27, 2023, 2:59 p.m.

    Author: Reuters

    LIVE MARKETS-Two COVID vaccine leaders, two different stories

    Published At: Jan. 27, 2023, 2:38 p.m.

    Author: Reuters

    LIVE MARKETS-Retail punters flock to favorite Tesla even as price jumps

    Published At: Jan. 27, 2023, 2:15 p.m.

    Author: Reuters

    U.S. RESEARCH ROUNDUP-Driven Brands Holdings, McCormick & Company, Standex International

    Published At: Jan. 27, 2023, 7:10 a.m.

    Author: Reuters

    U.S. RESEARCH ROUNDUP-Abbott Laboratories, Navient, Tesla

    Published At: Jan. 26, 2023, 8:38 a.m.

    Author: Reuters

    U.S. RESEARCH ROUNDUP-Abbott Laboratories, Navient Corp, Tesla

    Published At: Jan. 26, 2023, 7:42 a.m.

    Author: Reuters

    U.S. RESEARCH ROUNDUP-Enphase Energy, VF, Zions Bancorp

    Published At: Jan. 25, 2023, 10:17 p.m.

    Author: Reuters

    U.S. RESEARCH ROUNDUP-Enphase Energy, VF Corp, Zions Bancorporation

    Published At: Jan. 25, 2023, 3:40 p.m.

    Author: Reuters

    Carpenter Technology Corp <CRS.N>: Profits of 12 cents per share anticipated for fourth quarter

    Published At: Jan. 24, 2023, 2:14 p.m.

    Author: Reuters

    Aspen Technology Inc <AZPN.O>: Profits of $1.32 per share anticipated for fourth quarter

    Published At: Jan. 23, 2023, 10:25 p.m.

    Author: Reuters

    LIVE MARKETS-The market's hall of mirrors is no fun house -Morgan Stanley

    Published At: Jan. 23, 2023, 5:17 p.m.

    Author: Reuters

    LIVE MARKETS-Recession watch: Leading indicators point to economic downturn

    Published At: Jan. 23, 2023, 4 p.m.

    Author: Reuters

    LIVE MARKETS-Stay risk-off, says Citi

    Published At: Jan. 23, 2023, 3:11 p.m.

    Author: Reuters

    Nurix Therapeutics Inc <NRIX.O>: A loss of 79 cents per share anticipated for fourth quarter

    Published At: Jan. 23, 2023, 11:50 a.m.

    Author: Reuters

    Intuitive Surgical Inc <ISRG.O>: Profits of $1.25 per share anticipated for fourth quarter

    Published At: Jan. 20, 2023, 10:54 p.m.

    Author: Reuters

    AVITA Medical Inc <RCEL.O>: A loss of 29 cents per share anticipated for fourth quarter

    Published At: Jan. 20, 2023, 9:42 p.m.

    Author: Reuters

    LIVE MARKETS-S&P 500 earnings estimate weakens in the latest week

    Published At: Jan. 20, 2023, 6:38 p.m.

    Author: Reuters

    LIVE MARKETS-Big Tech to squeeze more revenue per employee with layoffs

    Published At: Jan. 20, 2023, 5:46 p.m.

    Author: Reuters

    Danaher Corp <DHR.N>: Profits of $2.51 per share anticipated for fourth quarter

    Published At: Jan. 20, 2023, 11:56 a.m.

    Author: Reuters

    U.S. RESEARCH ROUNDUP-Chegg, Hireright Holdings, Universal Display

    Published At: Jan. 19, 2023, 3:42 p.m.

    Author: Reuters

    LIVE MARKETS-Semis 'n software intrigue Nuveen

    Published At: Jan. 18, 2023, 6:16 p.m.

    Author: Reuters

    LIVE MARKETS-Retail traders bet Netflix to deliver earnings blockbuster

    Published At: Jan. 18, 2023, 6:02 p.m.

    Author: Reuters

    LIVE MARKETS-Don't bank on central banks for a rescue -BlackRock

    Published At: Jan. 18, 2023, 5:37 p.m.

    Author: Reuters

    LIVE MARKETS-Hump-day data dump: Retail sales, PPI, etc, etc

    Published At: Jan. 18, 2023, 5:17 p.m.

    Author: Reuters

    LIVE MARKETS-H1 2023 rally window is open -Stifel

    Published At: Jan. 10, 2023, 6:36 p.m.

    Author: Reuters

    Citigroup cuts U.S. stocks to 'underweight', favours European equities in 2023

    Published At: Jan. 6, 2023, 8:53 a.m.

    Author: Reuters

    LIVE MARKETS-A House divided gives rise to debt ceiling jitters

    Published At: Jan. 5, 2023, 6:15 p.m.

    Author: Reuters

    LIVE MARKETS-Themes that may dominate in 2023

    Published At: Jan. 5, 2023, 5:28 p.m.

    Author: Reuters

    LIVE MARKETS-The pursuit of offer letters

    Published At: Jan. 5, 2023, 5:04 p.m.

    Author: Reuters

    LIVE MARKETS-Thursday data swarm: Payrolls prologue fuels Fed fears

    Published At: Jan. 5, 2023, 4:25 p.m.

    Author: Reuters

    Microsoft shares lag Big Tech peers as growth worries prompt UBS downgrade

    Published At: Jan. 4, 2023, 3:34 p.m.

    Author: Reuters

    U.S. RESEARCH ROUNDUP- Boeing, Crown Holdings, Tesla

    Published At: Jan. 4, 2023, 9:08 a.m.

    Author: Reuters

    Simulations Plus Inc <SLP.O>: Profits of 9 cents per share anticipated for fourth quarter

    Published At: Jan. 2, 2023, 9:03 p.m.

    Author: Reuters

    LIVE MARKETS-Tesla advertises fewer jobs as uncertain 2023 beckons

    Published At: Dec. 30, 2022, 5:15 p.m.

    Author: Reuters

    LIVE MARKETS-Investing in stocks? Think very long term

    Published At: Dec. 30, 2022, 4:49 p.m.

    Author: Reuters

    LIVE MARKETS-Chicago PMI: The manufacturing ball-drop

    Published At: Dec. 30, 2022, 4:15 p.m.

    Author: Reuters

    LIVE MARKETS-Non-alignment comes in from the cold

    Published At: Dec. 30, 2022, 3:23 p.m.

    Author: Reuters

    LIVE MARKETS-Occidental Petroleum wins in 2022, Amazon and Tesla lose

    Published At: Dec. 29, 2022, 6:52 p.m.

    Author: Reuters

    LIVE MARKETS-Cryptos in 2023: Where there's smoke, there's fire

    Published At: Dec. 28, 2022, 7:28 p.m.

    Author: Reuters

    LIVE MARKETS-Too much pessimism for 2023

    Published At: Dec. 28, 2022, 6:16 p.m.

    Author: Reuters

    LIVE MARKETS-The five days that sent stocks tumbling in 2022

    Published At: Dec. 28, 2022, 5:05 p.m.

    Author: Reuters

    U.S. RESEARCH ROUNDUP-Amgen, Coupa Software, Enphase Energy

    Published At: Dec. 22, 2022, 3:11 p.m.

    Author: Reuters

    LIVE MARKETS-Tesla trims job posts as Musk reportedly eyes layoffs

    Published At: Dec. 21, 2022, 7:11 p.m.

    Author: Reuters

    U.S. RESEARCH ROUNDUP-Autodesk, Comerica, ZoomInfo Technologies

    Published At: Dec. 21, 2022, 5:55 p.m.

    Author: Reuters

    U.S. RESEARCH ROUNDUP- Best Buy Co, Dollar General, Walmart

    Published At: Dec. 20, 2022, 3:16 p.m.

    Author: Reuters

    Micron Technology Inc <MU.O>: A loss of 1 cents per share anticipated for fourth quarter

    Published At: Dec. 19, 2022, 9:02 p.m.

    Author: Reuters

    U.S. RESEARCH ROUNDUP-Glaukos, Invesco, Moderna

    Published At: Dec. 19, 2022, 6:17 p.m.

    Author: Reuters

    U.S. RESEARCH ROUNDUP-Glaukos Corp, Invesco, Moderna

    Published At: Dec. 19, 2022, 3:10 p.m.

    Author: Reuters

    NeuBase Therapeutics Inc <NBSE.O>: A loss of 28 cents per share anticipated for third quarter

    Published At: Dec. 19, 2022, 11:04 a.m.

    Author: Reuters

    U.S. RESEARCH ROUNDUP-Adobe, Costar Group, Verisign

    Published At: Dec. 16, 2022, 6:29 p.m.

    Author: Reuters

    Galmed Pharmaceuticals Ltd <GLMD.O>: A loss of 16 cents per share anticipated for fourth quarter

    Published At: Dec. 16, 2022, 1:39 p.m.

    Author: Reuters

    Outlook Therapeutics Inc <OTLK.O>: A loss of 7 cents per share anticipated for third quarter

    Published At: Dec. 16, 2022, 1:35 p.m.

    Author: Reuters

    U.S. RESEARCH ROUNDUP-Cognizant Technology Solutions, Fedex, Tesla

    Published At: Dec. 15, 2022, 5:58 p.m.

    Author: Reuters

    US STOCKS-Wall Street slides more than 1% on angst over hawkish Fed

    Published At: Dec. 15, 2022, 3:09 p.m.

    Author: Reuters

    U.S. RESEARCH ROUNDUP- Armstrong World, Eli Lilly, Netflix

    Published At: Dec. 14, 2022, 3:39 p.m.

    Author: Reuters

    U.S. RESEARCH ROUNDUP- Armstrong World Industries, Eli Lilly, Netflix

    Published At: Dec. 14, 2022, 10:16 a.m.

    Author: Reuters

    U.S. RESEARCH ROUNDUP-Amgen, Coupa Software, Zebra Technologies

    Published At: Dec. 13, 2022, 5:21 p.m.

    Author: Reuters

    Legend Biotech Corp <LEGN.O>: A loss of 39 cents per share anticipated for second quarter

    Published At: Dec. 9, 2022, 1:50 p.m.

    Author: Reuters

    S&P 500, Nasdaq snap losing streaks after jobless claims rise

    Published At: Dec. 8, 2022, 10 p.m.

    Author: Reuters

    US STOCKS-S&P 500, Nasdaq snap losing streaks after jobless claims rise

    Published At: Dec. 8, 2022, 9:59 p.m.

    Author: Reuters

    S&P 500 snaps losing streak on jobless claims rise

    Published At: Dec. 8, 2022, 9:11 p.m.

    Author: Reuters

    S&P 500 rebounds as investors take rate hike cues from jobless claims rise

    Published At: Dec. 8, 2022, 7:19 p.m.

    Author: Reuters

    US STOCKS-S&P 500 rebounds as investors take rate hike cues from jobless claims rise

    Published At: Dec. 8, 2022, 7:16 p.m.

    Author: Reuters

    US STOCKS-S&P 500 rebounds on tech boost; weekly jobless claims rise

    Published At: Dec. 8, 2022, 4:07 p.m.

    Author: Reuters

    Wall St set to open higher after recent slump

    Published At: Dec. 8, 2022, 2:16 p.m.

    Author: Reuters

    US STOCKS-Wall St set to open higher after recent slump

    Published At: Dec. 8, 2022, 2:12 p.m.

    Author: Reuters

    Futures edge up ahead of jobs data, recession fears loom

    Published At: Dec. 8, 2022, 12:10 p.m.

    Author: Reuters

    US STOCKS-Futures edge up ahead of jobs data, recession fears loom

    Published At: Dec. 8, 2022, 11:47 a.m.

    Author: Reuters

    LIVE MARKETS-Global value still more attractive than growth

    Published At: Dec. 2, 2022, 6:55 p.m.

    Author: Reuters

    LIVE MARKETS-Bulls dip to a 6-week low -AAII

    Published At: Dec. 2, 2022, 5:25 p.m.

    Author: Reuters

    LIVE MARKETS-Naughty and nice: A jobs report deep dive

    Published At: Dec. 2, 2022, 4:53 p.m.

    Author: Reuters

    U.S. RESEARCH ROUNDUP- Asana, Doordash, Nayax

    Published At: Dec. 2, 2022, 7:20 a.m.

    Author: Reuters

    U.S. RESEARCH ROUNDUP- Alcoa, Biogen, Workday

    Published At: Nov. 30, 2022, 10:35 p.m.

    Author: Reuters

    LIVE MARKETS-Wall Street jumps as Powell eases rate hike worries

    Published At: Nov. 30, 2022, 7:19 p.m.

    Author: Reuters

    LIVE MARKETS-Market decline likely between now and end of Q1-J.P. Morgan

    Published At: Nov. 30, 2022, 6:28 p.m.

    Author: Reuters

    U.S. RESEARCH ROUNDUP-Amazon.com, BorgWarner, Cincor Pharma

    Published At: Nov. 29, 2022, 5:58 p.m.

    Author: Reuters

    Venture capitalists flock to blockchain firms in third quarter - Pitchbook

    Published At: Nov. 29, 2022, 5:01 a.m.

    Author: Reuters

    Marvell Technology Inc <MRVL.O>: Profits of 59 cents per share anticipated for fourth quarter

    Published At: Nov. 29, 2022, 12:02 a.m.

    Author: Reuters

    U.S. RESEARCH ROUNDUP-First Solar, Live Nation Entertainment, Penn Entertainment

    Published At: Nov. 28, 2022, 5:54 p.m.

    Author: Reuters

    U.S. RESEARCH ROUNDUP-First Solar, Penn Entertainment, Live Nation Entertainment

    Published At: Nov. 28, 2022, 9:11 a.m.

    Author: Reuters

    Intuit Inc <INTU.O>: Profits of $1.22 per share anticipated for fourth quarter

    Published At: Nov. 28, 2022, 12:03 a.m.

    Author: Reuters

    Arrowhead Pharmaceuticals Inc <ARWR.O>: A loss of 17 cents per share anticipated for third quarter

    Published At: Nov. 25, 2022, 9:10 p.m.

    Author: Reuters

    U.S. RESEARCH ROUNDUP-Analog Devices, Deere & Co, Equifax

    Published At: Nov. 24, 2022, 3:24 p.m.

    Author: Reuters

    LIVE MARKETS-Wall St closes on an optimistic note

    Published At: Nov. 22, 2022, 9:36 p.m.

    Author: Reuters

    U.S. RESEARCH ROUNDUP-Freshworks, PowerSchool Holdings, Upland Software

    Published At: Nov. 22, 2022, 3:37 p.m.

    Author: Reuters

    Agilent Technologies Inc <A.N>: Profits of $1.39 per share anticipated for fourth quarter

    Published At: Nov. 18, 2022, 9:37 p.m.

    Author: Reuters

    Enanta Pharmaceuticals Inc <ENTA.O>: A loss of $1.35 per share anticipated for third quarter

    Published At: Nov. 18, 2022, 9:35 p.m.

    Author: Reuters

    U.S. RESEARCH ROUNDUP-Caterpillar, Endava, Harpoon Therapeutics

    Published At: Nov. 16, 2022, 4:41 p.m.

    Author: Reuters

    EUROPE RESEARCH ROUNDUP-Ashtead Technology Holdings, Delivery Hero, Kainos

    Published At: Nov. 16, 2022, 10:12 a.m.

    Author: Reuters

    Alpine Immune Sciences Inc <ALPN.O>: A loss of 10 cents per share anticipated for third quarter

    Published At: Nov. 12, 2022, 2:47 a.m.

    Author: Reuters

    Pear Therapeutics Inc <PEAR.O>: A loss of 21 cents per share anticipated for third quarter

    Published At: Nov. 12, 2022, 2:05 a.m.

    Author: Reuters

    Varex Imaging Corp <VREX.O>: Profits of 36 cents per share anticipated for third quarter

    Published At: Nov. 12, 2022, 1:49 a.m.

    Author: Reuters

    Achieve Life Sciences Inc <ACHV.O>: A loss of $1.13 per share anticipated for third quarter

    Published At: Nov. 12, 2022, 12:34 a.m.

    Author: Reuters

    Cymabay Therapeutics Inc <CBAY.O>: A loss of 30 cents per share anticipated for third quarter

    Published At: Nov. 12, 2022, 12:29 a.m.

    Author: Reuters

    Motus GI Holdings Inc <MOTS.O>: A loss of $1.88 per share anticipated for third quarter

    Published At: Nov. 12, 2022, 12:14 a.m.

    Author: Reuters

    Biotricity Inc <BTCY.O>: A loss of 7 cents per share anticipated for third quarter

    Published At: Nov. 11, 2022, 10:41 p.m.

    Author: Reuters

    Yield10 Bioscience Inc <YTEN.O>: A loss of 65 cents per share anticipated for third quarter

    Published At: Nov. 11, 2022, 10:17 p.m.

    Author: Reuters

    Lumos Pharma Inc <LUMO.O>: A loss of $1.01 per share anticipated for third quarter

    Published At: Nov. 11, 2022, 10:15 p.m.

    Author: Reuters

    Spero Therapeutics Inc <SPRO.O>: A loss of 30 cents per share anticipated for third quarter

    Published At: Nov. 11, 2022, 10:11 p.m.

    Author: Reuters

    Azenta Inc <AZTA.O>: Profits of 7 cents per share anticipated for third quarter

    Published At: Nov. 11, 2022, 9:18 p.m.

    Author: Reuters

    Syros Pharmaceuticals Inc <SYRS.O>: A loss of $4.01 per share anticipated for third quarter

    Published At: Nov. 11, 2022, 5:42 p.m.

    Author: Reuters

    PDS Biotechnology Corp <PDSB.O>: A loss of 28 cents per share anticipated for third quarter

    Published At: Nov. 11, 2022, 4:04 p.m.

    Author: Reuters

    908 Devices Inc. <MASS.O>: A loss of 22 cents per share anticipated for third quarter

    Published At: Nov. 11, 2022, 2:55 p.m.

    Author: Reuters

    Imunon Inc <IMNN.O>: A loss of 81 cents per share anticipated for third quarter

    Published At: Nov. 11, 2022, 2:48 p.m.

    Author: Reuters

    Abeona Therapeutics Inc <ABEO.O>: A loss of $1.75 per share anticipated for third quarter

    Published At: Nov. 11, 2022, 1:19 p.m.

    Author: Reuters

    Instil Bio Inc <TIL.O>: A loss of 44 cents per share anticipated for third quarter

    Published At: Nov. 11, 2022, 1:17 p.m.

    Author: Reuters

    LIVE MARKETS-Tech, growth drive fall in Q4 earnings estimates

    Published At: Nov. 10, 2022, 6:54 p.m.

    Author: Reuters

    U.S. RESEARCH ROUNDUP-Amyris, HanesBrands, Roblox

    Published At: Nov. 10, 2022, 1:44 p.m.

    Author: Reuters

    U.S. RESEARCH ROUNDUP-Beauty Health, Bioventus, Ouster

    Published At: Nov. 9, 2022, 12:34 p.m.

    Author: Reuters

    Neoleukin Therapeutics Inc <NLTX.O>: A loss of 30 cents per share anticipated for third quarter

    Published At: Nov. 9, 2022, 11:08 a.m.

    Author: Reuters

    Spectrum Pharmaceuticals Inc <SPPI.O>: A loss of 15 cents per share anticipated for third quarter

    Published At: Nov. 9, 2022, 3:01 a.m.

    Author: Reuters

    Rain Therapeutics Inc <RAIN.O>: A loss of 69 cents per share anticipated for third quarter

    Published At: Nov. 9, 2022, 2:21 a.m.

    Author: Reuters

    Co-Diagnostics Inc <CODX.O>: A loss of 4 cents per share anticipated for third quarter

    Published At: Nov. 9, 2022, 2:16 a.m.

    Author: Reuters

    Celcuity Inc <CELC.O>: A loss of 58 cents per share anticipated for third quarter

    Published At: Nov. 9, 2022, 1:39 a.m.

    Author: Reuters

    T2 Biosystems Inc <TTOO.O>: A loss of $2.04 per share anticipated for third quarter

    Published At: Nov. 9, 2022, 1:36 a.m.

    Author: Reuters

    BIOLASE Inc <BIOL.O>: A loss of 84 cents per share anticipated for third quarter

    Published At: Nov. 9, 2022, 1:32 a.m.

    Author: Reuters

    ICAD Inc <ICAD.O>: A loss of 13 cents per share anticipated for third quarter

    Published At: Nov. 9, 2022, 12:55 a.m.

    Author: Reuters

    LIVE MARKETS-U.S. stocks get election-day bump, but bitcoin gets belted

    Published At: Nov. 8, 2022, 9:18 p.m.

    Author: Reuters

    IsoPlexis Corp <ISO.O>: A loss of 43 cents per share anticipated for third quarter

    Published At: Nov. 8, 2022, 7:42 p.m.

    Author: Reuters

    MoneyLion Inc <ML.N>: A loss of 12 cents per share anticipated for third quarter

    Published At: Nov. 8, 2022, 7:38 p.m.

    Author: Reuters

    Savara Inc <SVRA.O>: A loss of 7 cents per share anticipated for third quarter

    Published At: Nov. 8, 2022, 7:38 p.m.

    Author: Reuters

    Humacyte Inc <HUMA.O>: A loss of 21 cents per share anticipated for third quarter

    Published At: Nov. 8, 2022, 7:38 p.m.

    Author: Reuters

    Gain Therapeutics Inc <GANX.O>: A loss of 46 cents per share anticipated for third quarter

    Published At: Nov. 8, 2022, 7:37 p.m.

    Author: Reuters

    Passage Bio Inc <PASG.O>: A loss of 79 cents per share anticipated for third quarter

    Published At: Nov. 8, 2022, 7:36 p.m.

    Author: Reuters

    Applied Therapeutics Inc <APLT.O>: A loss of 48 cents per share anticipated for third quarter

    Published At: Nov. 8, 2022, 7:36 p.m.

    Author: Reuters

    BioXcel Therapeutics Inc <BTAI.O>: A loss of $1.35 per share anticipated for third quarter

    Published At: Nov. 8, 2022, 7:33 p.m.

    Author: Reuters

    CORRECTED-U.S. RESEARCH ROUNDUP-Linkbancorp, Oyster Point Pharma, Viatris

    Published At: Nov. 8, 2022, 4:58 p.m.

    Author: Reuters

    Angion Biomedica Corp <ANGN.O>: A loss of 36 cents per share anticipated for third quarter

    Published At: Nov. 8, 2022, 4:29 p.m.

    Author: Reuters

    Dynatronics Corp <DYNT.O>: A loss of 6 cents per share anticipated for third quarter

    Published At: Nov. 8, 2022, 4:17 p.m.

    Author: Reuters

    Dare Bioscience Inc <DARE.O>: A loss of 12 cents per share anticipated for third quarter

    Published At: Nov. 8, 2022, 4:11 p.m.

    Author: Reuters

    Sellas Life Sciences Group Inc <SLS.O>: A loss of 39 cents per share anticipated for third quarter

    Published At: Nov. 8, 2022, 2:40 p.m.

    Author: Reuters

    Monopar Therapeutics Inc <MNPR.O>: A loss of 22 cents per share anticipated for third quarter

    Published At: Nov. 8, 2022, 1:10 p.m.

    Author: Reuters

    Prelude Therapeutics Inc <PRLD.O>: A loss of 64 cents per share anticipated for third quarter

    Published At: Nov. 8, 2022, 1:01 p.m.

    Author: Reuters

    U.S. RESEARCH ROUNDUP-Linkbancorp, Oyster Point Pharma, Viatris

    Published At: Nov. 8, 2022, 12:55 p.m.

    Author: Reuters

    Rackspace Technology Inc <RXT.O>: Profits of 9 cents per share anticipated for third quarter

    Published At: Nov. 8, 2022, 3:14 a.m.

    Author: Reuters

    BioCardia Inc <BCDA.O>: A loss of 23 cents per share anticipated for third quarter

    Published At: Nov. 8, 2022, 3:14 a.m.

    Author: Reuters

    Viant Technology Inc <DSP.O>: A loss of 18 cents per share anticipated for third quarter

    Published At: Nov. 8, 2022, 3:13 a.m.

    Author: Reuters

    Relmada Therapeutics Inc <RLMD.O>: A loss of $1.45 per share anticipated for third quarter

    Published At: Nov. 8, 2022, 3:13 a.m.

    Author: Reuters

    Transphorm Technology Inc <TGAN.O>: A loss of 10 cents per share anticipated for third quarter

    Published At: Nov. 8, 2022, 3:12 a.m.

    Author: Reuters

    Curis Inc <CRIS.O>: A loss of 17 cents per share anticipated for third quarter

    Published At: Nov. 8, 2022, 2:14 a.m.

    Author: Reuters

    Minerva Neurosciences Inc <NERV.O>: A loss of $1.32 per share anticipated for third quarter

    Published At: Nov. 7, 2022, 7:35 p.m.

    Author: Reuters

    Clearside Biomedical Inc <CLSD.O>: A loss of 3 cents per share anticipated for third quarter

    Published At: Nov. 7, 2022, 5:24 p.m.

    Author: Reuters

    U.S. RESEARCH ROUNDUP-Avalonbay Communities, Dominion Energy, PayPal Holdings

    Published At: Nov. 7, 2022, 5:16 p.m.

    Author: Reuters

    GlycoMimetics Inc <GLYC.O>: A loss of 26 cents per share anticipated for third quarter

    Published At: Nov. 7, 2022, 4:35 p.m.

    Author: Reuters

    Ionis Pharmaceuticals Inc <IONS.O>: A loss of 74 cents per share anticipated for third quarter

    Published At: Nov. 7, 2022, 3:43 p.m.

    Author: Reuters

    ALX Oncology Holdings Inc <ALXO.O>: A loss of 77 cents per share anticipated for third quarter

    Published At: Nov. 7, 2022, 11:08 a.m.

    Author: Reuters

    Vaxcyte Inc <PCVX.O>: A loss of 84 cents per share anticipated for third quarter

    Published At: Nov. 5, 2022, 2:53 a.m.

    Author: Reuters

    Rapt Therapeutics Inc <RAPT.O>: A loss of 67 cents per share anticipated for third quarter

    Published At: Nov. 5, 2022, 1:24 a.m.

    Author: Reuters

    Singular Genomics Systems Inc <OMIC.O>: A loss of 41 cents per share anticipated for third quarter

    Published At: Nov. 5, 2022, 12:52 a.m.

    Author: Reuters

    DiaMedica Therapeutics Inc <DMAC.O>: A loss of 15 cents per share anticipated for third quarter

    Published At: Nov. 4, 2022, 11:56 p.m.

    Author: Reuters

    Albireo Pharma Inc <ALBO.O>: A loss of $1.06 per share anticipated for third quarter

    Published At: Nov. 4, 2022, 11:36 p.m.

    Author: Reuters

    Ligand Pharmaceuticals Inc <LGND.O>: Profits of 43 cents per share anticipated for third quarter

    Published At: Nov. 4, 2022, 11:28 p.m.

    Author: Reuters

    Revance Therapeutics Inc <RVNC.O>: A loss of 89 cents per share anticipated for third quarter

    Published At: Nov. 4, 2022, 11:18 p.m.

    Author: Reuters

    Health Catalyst Inc <HCAT.O>: A loss of 19 cents per share anticipated for third quarter

    Published At: Nov. 4, 2022, 11:08 p.m.

    Author: Reuters

    Avid Technology Inc <AVID.O>: Profits of 31 cents per share anticipated for third quarter

    Published At: Nov. 4, 2022, 11:04 p.m.

    Author: Reuters

    Shattuck Labs Inc <STTK.O>: A loss of 67 cents per share anticipated for third quarter

    Published At: Nov. 4, 2022, 7:41 p.m.

    Author: Reuters

    SAGE Therapeutics Inc <SAGE.O>: A loss of $2.21 per share anticipated for third quarter

    Published At: Nov. 4, 2022, 7:41 p.m.

    Author: Reuters

    Reata Pharmaceuticals Inc <RETA.O>: A loss of $2.18 per share anticipated for third quarter

    Published At: Nov. 4, 2022, 7:40 p.m.

    Author: Reuters

    Amicus Therapeutics Inc <FOLD.O>: A loss of 19 cents per share anticipated for third quarter

    Published At: Nov. 4, 2022, 7:40 p.m.

    Author: Reuters

    Synlogic Inc <SYBX.O>: A loss of 23 cents per share anticipated for third quarter

    Published At: Nov. 4, 2022, 7:40 p.m.

    Author: Reuters

    Embark Technology Inc <EMBK.O>: A loss of $1.58 per share anticipated for third quarter

    Published At: Nov. 4, 2022, 7:39 p.m.

    Author: Reuters

    Aridis Pharmaceuticals Inc <ARDS.O>: A loss of 17 cents per share anticipated for third quarter

    Published At: Nov. 4, 2022, 7:39 p.m.

    Author: Reuters

    Sutro Biopharma Inc <STRO.O>: A loss of 74 cents per share anticipated for third quarter

    Published At: Nov. 4, 2022, 7:39 p.m.

    Author: Reuters

    Ocugen Inc <OCGN.O>: A loss of 10 cents per share anticipated for third quarter

    Published At: Nov. 4, 2022, 7:39 p.m.

    Author: Reuters

    MannKind Corp <MNKD.O>: A loss of 9 cents per share anticipated for third quarter

    Published At: Nov. 4, 2022, 7:39 p.m.

    Author: Reuters

    Voyager Therapeutics Inc <VYGR.O>: A loss of 32 cents per share anticipated for third quarter

    Published At: Nov. 4, 2022, 7:38 p.m.

    Author: Reuters

    Black Diamond Therapeutics Inc <BDTX.O>: A loss of 64 cents per share anticipated for third quarter

    Published At: Nov. 4, 2022, 6:52 p.m.

    Author: Reuters

    Concert Pharmaceuticals Inc <CNCE.O>: A loss of 59 cents per share anticipated for third quarter

    Published At: Nov. 4, 2022, 6:52 p.m.

    Author: Reuters

    eFFECTOR Therapeutics Inc <EFTR.O>: A loss of 21 cents per share anticipated for third quarter

    Published At: Nov. 4, 2022, 6:31 p.m.

    Author: Reuters

    Legend Biotech Corp <LEGN.O>: A loss of 34 cents per share anticipated for second quarter

    Published At: Nov. 4, 2022, 6:31 p.m.

    Author: Reuters

    Scholar Rock Holding Corp <SRRK.O>: A loss of 69 cents per share anticipated for third quarter

    Published At: Nov. 4, 2022, 6:13 p.m.

    Author: Reuters

    UNITY Biotechnology Inc <UBX.O>: A loss of $1.65 per share anticipated for third quarter

    Published At: Nov. 4, 2022, 6:12 p.m.

    Author: Reuters

    VBI Vaccines Inc <VBIV.O>: A loss of 8 cents per share anticipated for third quarter

    Published At: Nov. 4, 2022, 6:06 p.m.

    Author: Reuters

    Tango Therapeutics Inc <TNGX.O>: A loss of 32 cents per share anticipated for third quarter

    Published At: Nov. 4, 2022, 5:25 p.m.

    Author: Reuters

    Stoke Therapeutics Inc <STOK.O>: A loss of 68 cents per share anticipated for third quarter

    Published At: Nov. 4, 2022, 5:23 p.m.

    Author: Reuters

    Kodiak Sciences Inc <KOD.O>: A loss of $1.77 per share anticipated for third quarter

    Published At: Nov. 4, 2022, 5:11 p.m.

    Author: Reuters

    TCR2 Therapeutics Inc <TCRR.O>: A loss of 83 cents per share anticipated for third quarter

    Published At: Nov. 4, 2022, 5:11 p.m.

    Author: Reuters

    Beam Therapeutics Inc <BEAM.O>: A loss of $1.31 per share anticipated for third quarter

    Published At: Nov. 4, 2022, 5:11 p.m.

    Author: Reuters

    Inozyme Pharma Inc <INZY.O>: A loss of 43 cents per share anticipated for third quarter

    Published At: Nov. 4, 2022, 5:11 p.m.

    Author: Reuters

    Cassava Sciences Inc <SAVA.O>: A loss of 48 cents per share anticipated for third quarter

    Published At: Nov. 4, 2022, 5:10 p.m.

    Author: Reuters

    Inhibrx Inc <INBX.O>: A loss of 94 cents per share anticipated for third quarter

    Published At: Nov. 4, 2022, 5:09 p.m.

    Author: Reuters

    Marker Therapeutics Inc <MRKR.O>: A loss of 12 cents per share anticipated for third quarter

    Published At: Nov. 4, 2022, 5:06 p.m.

    Author: Reuters

    Capricor Therapeutics Inc <CAPR.O>: A loss of 29 cents per share anticipated for third quarter

    Published At: Nov. 4, 2022, 2:43 p.m.

    Author: Reuters

    Astria Therapeutics Inc <ATXS.O>: A loss of 92 cents per share anticipated for third quarter

    Published At: Nov. 4, 2022, 2:31 p.m.

    Author: Reuters

    Kezar Life Sciences Inc <KZR.O>: A loss of 27 cents per share anticipated for third quarter

    Published At: Nov. 4, 2022, 12:48 p.m.

    Author: Reuters

    Pacific Biosciences of California Inc <PACB.O>: A loss of 33 cents per share anticipated for third quarter

    Published At: Nov. 4, 2022, 12:40 p.m.

    Author: Reuters

    SQZ Biotechnologies Co <SQZ.N>: A loss of 83 cents per share anticipated for third quarter

    Published At: Nov. 4, 2022, 11:58 a.m.

    Author: Reuters

    Applied Molecular Transport Inc. <AMTI.O>: A loss of 65 cents per share anticipated for third quarter

    Published At: Nov. 4, 2022, 11 a.m.

    Author: Reuters

    U.S. RESEARCH ROUNDUP-Altice USA, C4 Therapeutics, Lincoln National

    Published At: Nov. 4, 2022, 10:54 a.m.

    Author: Reuters

    U.S. RESEARCH ROUNDUP-ACI Worldwide, Kaman, Sinclair Broadcast Group

    Published At: Nov. 3, 2022, 4:02 p.m.

    Author: Reuters

    U.S. RESEARCH ROUNDUP-Avista, IPG Photonics, Seaspine

    Published At: Nov. 2, 2022, 6:09 p.m.

    Author: Reuters

    ImmunoGen Inc <IMGN.O>: A loss of 25 cents per share anticipated for third quarter

    Published At: Nov. 2, 2022, 6:07 p.m.

    Author: Reuters

    U.S. RESEARCH ROUNDUP-Avista, IPG Photonics, Seaspine Holdings

    Published At: Nov. 2, 2022, 3:25 p.m.

    Author: Reuters

    Syneos Health Inc <SYNH.O>: Profits of $1.32 per share anticipated for third quarter

    Published At: Nov. 2, 2022, 2:18 p.m.

    Author: Reuters

    Cytokinetics Inc <CYTK.O>: A loss of $1.17 per share anticipated for third quarter

    Published At: Nov. 2, 2022, 2:16 a.m.

    Author: Reuters

    Rigel Pharmaceuticals Inc <RIGL.O>: A loss of 13 cents per share anticipated for third quarter

    Published At: Nov. 2, 2022, 2:15 a.m.

    Author: Reuters

    Ventyx Biosciences Inc <VTYX.O>: A loss of 44 cents per share anticipated for third quarter

    Published At: Nov. 2, 2022, 2:14 a.m.

    Author: Reuters

    Exact Sciences Corp <EXAS.O>: A loss of $1.08 per share anticipated for third quarter

    Published At: Nov. 2, 2022, 2:14 a.m.

    Author: Reuters

    Bioatla Inc <BCAB.O>: A loss of 80 cents per share anticipated for third quarter

    Published At: Nov. 2, 2022, 2:11 a.m.

    Author: Reuters

    Cytosorbents Corp <CTSO.O>: A loss of 16 cents per share anticipated for third quarter

    Published At: Nov. 2, 2022, 2:11 a.m.

    Author: Reuters

    Galapagos NV <GLPG.O>: A loss of €1.05 per share anticipated for third quarter

    Published At: Nov. 2, 2022, 2:11 a.m.

    Author: Reuters

    DXC Technology Co <DXC.N>: Profits of 73 cents per share anticipated for third quarter

    Published At: Nov. 2, 2022, 1:25 a.m.

    Author: Reuters

    bluebird bio Inc <BLUE.O>: A loss of $1.12 per share anticipated for third quarter

    Published At: Nov. 1, 2022, 6:38 p.m.

    Author: Reuters

    IVERIC bio Inc <ISEE.O>: A loss of 40 cents per share anticipated for third quarter

    Published At: Nov. 1, 2022, 6:37 p.m.

    Author: Reuters

    Fidelity National Information Services Inc <FIS.N>: Profits of $1.75 per share anticipated for third quarter

    Published At: Nov. 1, 2022, 6:37 p.m.

    Author: Reuters

    X4 Pharmaceuticals Inc <XFOR.O>: A loss of 30 cents per share anticipated for third quarter

    Published At: Nov. 1, 2022, 6:36 p.m.

    Author: Reuters

    Provention Bio Inc <PRVB.O>: A loss of 42 cents per share anticipated for third quarter

    Published At: Nov. 1, 2022, 6:36 p.m.

    Author: Reuters

    Regenxbio Inc <RGNX.O>: A loss of $1.46 per share anticipated for third quarter

    Published At: Nov. 1, 2022, 1:13 p.m.

    Author: Reuters

    Immunic Inc <IMUX.O>: A loss of 66 cents per share anticipated for third quarter

    Published At: Nov. 1, 2022, 1:12 p.m.

    Author: Reuters

    Ironwood Pharmaceuticals Inc <IRWD.O>: Profits of 26 cents per share anticipated for third quarter

    Published At: Nov. 1, 2022, 1:10 p.m.

    Author: Reuters

    Kymera Therapeutics Inc <KYMR.O>: A loss of 74 cents per share anticipated for third quarter

    Published At: Nov. 1, 2022, 12:08 p.m.

    Author: Reuters

    Similar Companies

    Symbol Title
    FTNT Fortinet Inc
    ITP IT Tech Packaging, Inc.,
    GENI Genius Sports Limited
    CLFD Clearfield, Inc.
    LIDR AEye, Inc.
    CLBT Cellebrite DI Ltd.
    DBD Diebold Nixdorf Incorporated
    MODN Model N, Inc.

    Profile

    Company Overview: Maximus, Inc. (NYSE: MMS) specializes in business process services (BPS) for the health and human service industries. Its operating segments are 1) US Services Segment, which offers a variety of BPS, such as program administration, appeals and assessments, and related consultancy work to US state and local government programs, 2) US Federal Services Segment, which provides BPS solutions for a wide range of US federal civilian activities, including system and software development and maintenance and 3) Outside the US Segment, includes health and disability assessments, programme administration for employment assistance, and other job seeker-related services to governments and commercial customers in countries other than the US.

    Market Research

    Our Company

    Useful Links

    Contact Us

    Disclaimer

    Kalkine Equities LLC., having Delaware File Number 4697384 is authorised to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. Before you make a decision about whether to acquire a financial product, you should obtain the Product Disclosure Statement from the product issuer. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions.

    The link to our Terms & Conditions and Privacy Policy of our services have been provided for your reference.

    Copyright © 2023 Krish Capital Pty Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.

    We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to this. Read our Privacy Policy and Terms and Conditions

    I Agree Decline